Cyanotech Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Cyanotech şirketinin toplam hissedar öz sermayesi $10.7M ve toplam borcu $6.5M olup, bu da borç-öz sermaye oranını 60.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $24.4M ve $13.8M dir.

Anahtar bilgiler

60.5%

Borç/özkaynak oranı

US$6.45m

Borç

Faiz karşılama oranı	n/a
Nakit	US$720.00k
Eşitlik	US$10.66m
Toplam yükümlülükler	US$13.77m
Toplam varlıklar	US$24.43m

Son finansal sağlık güncellemeleri

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Feb 09

Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?

Oct 05

Recent updates

Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%

Feb 15

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Feb 09

Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?

Oct 05

There's Been No Shortage Of Growth Recently For Cyanotech's (NASDAQ:CYAN) Returns On Capital

Sep 30

These 4 Measures Indicate That Cyanotech (NASDAQ:CYAN) Is Using Debt Reasonably Well

Feb 08

Returns On Capital Tell Us A Lot About Cyanotech (NASDAQ:CYAN)

Jan 04

Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 30

Cyanotech reports Q2 results

Nov 12

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CYAN 'nin kısa vadeli varlıkları ( $10.4M ) kısa vadeli yükümlülüklerini ( $10.2M ) aşıyor.

Uzun Vadeli Yükümlülükler: CYAN şirketinin kısa vadeli varlıkları ( $10.4M ) uzun vadeli yükümlülüklerini ( $3.6M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CYAN 'nin net borç/öz sermaye oranı ( 53.8% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: CYAN 'nin borç/öz sermaye oranı son 5 yılda 61% seviyesinden 60.5% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: Kârsız olan CYAN mevcut pozitif serbest nakit akışı seviyesini koruduğu takdirde 3 yıldan fazla yetecek nakit pistine sahip olacaktır.

Tahmini Nakit Akışı: CYAN kârlı değildir ancak serbest nakit akışı pozitif olsa ve yılda 5.7 % oranında azalsa bile 3 yıldan fazla bir süre yetecek nakit akışına sahiptir.

Cyanotech Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

The Nasdaq Stock Market to Delist the Common Stock of Cyanotech

Cyanotech Receives Notification Letter from The Nasdaq Stock Market LLC Regarding Not Regains Compliance with the Bid Price Rule and Not Eligible for Second 180-Day Period

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?

Cyanotech Receives Notification Letter from Nasdaq Regarding Non-Compliance with Minimum Bid Price Requirement for its Common Stock

Cyanotech Receives a Notification Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC Regarding Bid Price Rule

Recent updates

Cyanotech Corporation Announces CFO Changes

Cyanotech Corporation Announces CFO Changes

Cyanotech Corporation, Annual General Meeting, Aug 22, 2024

The Nasdaq Stock Market to Delist the Common Stock of Cyanotech

Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index

Cyanotech Corporation(NasdaqCM:CYAN) dropped from NASDAQ Composite Index

New minor risk - Share price stability

Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%

Cyanotech Receives Notification Letter from The Nasdaq Stock Market LLC Regarding Not Regains Compliance with the Bid Price Rule and Not Eligible for Second 180-Day Period

New major risk - Financial position

Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?

Third quarter 2024 earnings released: US$0.16 loss per share (vs US$0.095 loss in 3Q 2023)

Second quarter 2024 earnings released: US$0.13 loss per share (vs US$0.15 loss in 2Q 2023)

Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?

First quarter 2024 earnings released: US$0.22 loss per share (vs US$0.076 loss in 1Q 2023)

Cyanotech Receives Notification Letter from Nasdaq Regarding Non-Compliance with Minimum Bid Price Requirement for its Common Stock

Cyanotech Corporation Appoints Collette Kakuk as Chief Strategic and Commercial Officer

Cyanotech Corporation, Annual General Meeting, Aug 24, 2023

New minor risk - Share price stability

Full year 2023 earnings released: US$0.55 loss per share (vs US$0.35 profit in FY 2022)

Cyanotech Receives a Notification Letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC Regarding Bid Price Rule

Third quarter 2023 earnings released: US$0.095 loss per share (vs US$0.062 profit in 3Q 2022)

Second quarter 2023 earnings released: US$0.15 loss per share (vs US$0.16 profit in 2Q 2022)

Investor sentiment improved over the past week

There's Been No Shortage Of Growth Recently For Cyanotech's (NASDAQ:CYAN) Returns On Capital

Investor sentiment deteriorated over the past week

Here's Why Cyanotech (NASDAQ:CYAN) Can Manage Its Debt Responsibly

First quarter 2023 earnings released: US$0.076 loss per share (vs US$0.085 profit in 1Q 2022)

Cyanotech GAAP EPS of -$0.08, revenue of $6.72M

Cyanotech Corporation, Annual General Meeting, Aug 25, 2022

Cyanotech Corporation Announces Management Changes

Full year 2022 earnings released: EPS: US$0.35 (vs US$0.15 in FY 2021)

Cyanotech (NASDAQ:CYAN) Might Have The Makings Of A Multi-Bagger

Is Cyanotech (NASDAQ:CYAN) A Risky Investment?

Insufficient new directors

The ESG Future Of Food Protein Production: Cyanotech

Cyanotech (NASDAQ:CYAN) Is Doing The Right Things To Multiply Its Share Price

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

We Think Cyanotech (NASDAQ:CYAN) Can Stay On Top Of Its Debt

Independent Chairman of the Board recently bought US$126k worth of stock

Cyanotech (NASDAQ:CYAN) Is Experiencing Growth In Returns On Capital

Second quarter 2022 earnings released: EPS US$0.16 (vs US$0.026 in 2Q 2021)

First quarter 2022 earnings released: EPS US$0.085 (vs US$0.023 in 1Q 2021)

Full year 2021 earnings released: EPS US$0.15 (vs US$0.065 in FY 2020)

Cyanotech (NASDAQ:CYAN) Is Carrying A Fair Bit Of Debt

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: US$4.12

Cyanotech's (NASDAQ:CYAN) Promising Earnings May Rest On Soft Foundations

Third quarter 2021 earnings released: EPS US$0.14 (vs US$0.029 in 3Q 2020)

New 90-day high: US$3.92

These 4 Measures Indicate That Cyanotech (NASDAQ:CYAN) Is Using Debt Reasonably Well

New 90-day high: US$3.40

New 90-day high: US$3.22

Returns On Capital Tell Us A Lot About Cyanotech (NASDAQ:CYAN)

New 90-day high: US$3.17

Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Independent Director recently sold US$108k worth of stock

Second quarter 2021 earnings released: EPS US$0.026

Cyanotech reports Q2 results

Market bids up stock over the past week

Market bids up stock over the past week

Cyanotech Corporation Launches Bioastin

New 90-day high - US$2.85

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin